These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 22673153)
1. Spotlight on the role of COP1 in tumorigenesis. Marine JC Nat Rev Cancer; 2012 Jun; 12(7):455-64. PubMed ID: 22673153 [TBL] [Abstract][Full Text] [Related]
2. Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin. Sanchez-Barcelo EJ; Mediavilla MD; Vriend J; Reiter RJ J Pineal Res; 2016 Aug; 61(1):41-51. PubMed ID: 27121162 [TBL] [Abstract][Full Text] [Related]
3. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis. Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432 [TBL] [Abstract][Full Text] [Related]
4. COP1 - from plant photomorphogenesis to mammalian tumorigenesis. Yi C; Deng XW Trends Cell Biol; 2005 Nov; 15(11):618-25. PubMed ID: 16198569 [TBL] [Abstract][Full Text] [Related]
5. Role of the COP1 protein in cancer development and therapy. Song Y; Liu Y; Pan S; Xie S; Wang ZW; Zhu X Semin Cancer Biol; 2020 Dec; 67(Pt 2):43-52. PubMed ID: 32027978 [TBL] [Abstract][Full Text] [Related]
6. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399 [TBL] [Abstract][Full Text] [Related]
7. COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435 [TBL] [Abstract][Full Text] [Related]
8. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer. Satija YK; Bhardwaj A; Das S Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247 [TBL] [Abstract][Full Text] [Related]
9. A COP1-PIF-HEC regulatory module fine-tunes photomorphogenesis in Arabidopsis. Kathare PK; Xu X; Nguyen A; Huq E Plant J; 2020 Sep; 104(1):113-123. PubMed ID: 32652745 [TBL] [Abstract][Full Text] [Related]
10. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Choi HH; Gully C; Su CH; Velazquez-Torres G; Chou PC; Tseng C; Zhao R; Phan L; Shaiken T; Chen J; Yeung SC; Lee MH Oncogene; 2011 Dec; 30(48):4791-801. PubMed ID: 21625211 [TBL] [Abstract][Full Text] [Related]
11. Glucose-induced CRL4 Su Y; Luo Y; Zhang P; Lin H; Pu W; Zhang H; Wang H; Hao Y; Xiao Y; Zhang X; Wei X; Nie S; Zhang K; Fu Q; Chen H; Huang N; Ren Y; Wu M; Chow BKC; Chen X; Jin W; Wang F; Zhao L; Rao F Mol Cell; 2023 Jul; 83(13):2316-2331.e7. PubMed ID: 37390815 [TBL] [Abstract][Full Text] [Related]
12. Good COP1 or bad COP1? In vivo veritas. Wei W; Kaelin WG J Clin Invest; 2011 Apr; 121(4):1263-5. PubMed ID: 21403396 [TBL] [Abstract][Full Text] [Related]
13. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53. Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417 [TBL] [Abstract][Full Text] [Related]
14. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761 [TBL] [Abstract][Full Text] [Related]
15. Targeting the ubiquitin pathway for cancer treatment. Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052 [TBL] [Abstract][Full Text] [Related]
16. Hedgehog/Gli control by ubiquitination/acetylation interplay. Gulino A; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I Vitam Horm; 2012; 88():211-27. PubMed ID: 22391305 [TBL] [Abstract][Full Text] [Related]
17. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224 [TBL] [Abstract][Full Text] [Related]
18. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines. Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369 [TBL] [Abstract][Full Text] [Related]
19. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction. Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424 [TBL] [Abstract][Full Text] [Related]
20. Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. Ramkumar C; Kong Y; Cui H; Hao S; Jones SN; Gerstein RM; Zhang H Cancer Res; 2012 Jun; 72(11):2714-9. PubMed ID: 22552287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]